# RAB9A

## Overview
RAB9A is a gene that encodes a small GTPase protein, which is a member of the RAS oncogene family. The RAB9A protein is primarily involved in intracellular vesicular trafficking, particularly in the transport of proteins from late endosomes to the trans-Golgi network (TGN). This function is crucial for the recycling of mannose 6-phosphate receptors and the proper sorting of lysosomal enzymes, thereby maintaining cellular homeostasis (Lombardi1993Rab9; Ganley2004Rab9). Structurally, RAB9A features a GTP-binding domain and undergoes post-translational modifications such as prenylation, which are essential for its membrane association and function (Mackiewicz2009Phylogeny). The protein interacts with various effectors, including TIP47 and the retromer complex, to facilitate its role in endosomal trafficking and viral processes (Ganley2004Rab9; Choi2023Noncanonical). Clinically, alterations in RAB9A expression have been linked to several cancers, including hepatocellular carcinoma, melanoma, and osteosarcoma, highlighting its potential as a therapeutic target (Wu2023Isoliquiritigenin; Ouyang2021Loss).

## Structure
RAB9A is a small GTPase involved in vesicular trafficking, belonging to the RAS oncogene family. The protein's primary structure consists of a sequence of amino acids that form a characteristic GTP-binding domain. Its secondary structure includes six beta-sheets and five alpha-helices, which are typical of Rab GTPases (Barnekow2009Chapter). The tertiary structure of RAB9A results in a compact, globular shape, facilitating its role in membrane trafficking. This structure is stabilized by interactions with effector proteins, such as TIP47, which are crucial for its function and stability on late endosomes (Ganley2004Rab9).

RAB9A undergoes post-translational modifications, including prenylation at its C-terminal prenylation motif, which is essential for membrane attachment (Mackiewicz2009Phylogeny). The protein's quaternary structure involves interactions with other proteins, such as BLOC-3, which specifically binds to RAB9A in its GTP-bound form, highlighting the importance of its switch I and switch II regions for effector binding (Kloer2010Assembly). These interactions are mediated through a canonical effector-binding surface, which includes a hydrophobic triad crucial for binding specificity (Kloer2010Assembly).

## Function
Rab9A is a small GTPase that plays a crucial role in intracellular vesicle trafficking, particularly in the transport of proteins from late endosomes to the trans-Golgi network (TGN). This transport is essential for the recycling of mannose 6-phosphate receptors (MPRs), which are responsible for carrying lysosomal enzymes from the TGN to late endosomes, ensuring proper lysosomal enzyme delivery and protein sorting within cells (Lombardi1993Rab9; Ganley2004Rab9).

Rab9A is also involved in the biogenesis and maturation of melanosomes, specialized organelles responsible for pigment production in melanocytes. It facilitates the transport of melanin-synthesizing enzymes, such as TYRP1 and TYR, from recycling endosomes to melanosomes. In Rab9A-depleted melanocytes, these enzymes are mislocalized to lysosomes, leading to their degradation and resulting in hypopigmented melanosomes (Mahanty2015Rab9A).

Rab9A's function is dependent on its prenylation, a post-translational modification that allows it to associate with cellular membranes. This modification is crucial for its role in vesicle targeting and fusion, as well as for maintaining the stability and size of late endosomes (Lombardi1993Rab9; Ganley2004Rab9).

## Clinical Significance
Alterations in the expression of the RAB9A gene have been implicated in various cancers, including hepatocellular carcinoma (HCC), melanoma, and osteosarcoma. In HCC, the loss of androgen receptor (AR) under hypoxic conditions leads to increased RAB9A expression, promoting cell invasion and metastasis through the circ-LNPEP/miR-532-3p/RAB9A signaling pathway. High levels of RAB9A correlate with advanced tumor stages and poorer overall survival in HCC patients (Ouyang2021Loss).

In melanoma, RAB9A is regulated by multiple non-coding RNAs, including circ_0002860 and ZFAS1, which modulate its expression through miR-431-5p and miR-150-5p, respectively. These interactions contribute to melanoma progression by affecting cell proliferation, migration, and invasion. Isoliquiritigenin (ISL) has been shown to inhibit melanoma growth by targeting the circ_0002860/miR-431-5p/RAB9A axis (Wu2023Isoliquiritigenin; Liang2019Long).

In osteosarcoma, RAB9A expression is increased by circSIPA1L1, which acts as a sponge for miR-411-5p. This upregulation promotes tumor progression by enhancing cell proliferation, migration, and invasion (Xu2021Circular). These findings suggest that RAB9A plays a significant role in cancer development and could be a potential target for therapeutic strategies.

## Interactions
RAB9A, a member of the RAS oncogene family, is involved in various protein interactions crucial for its role in intracellular trafficking. RAB9A interacts with the retromer complex, which is essential for the retrograde trafficking of proteins from endosomes to the trans-Golgi network (TGN). This interaction is particularly significant in the context of human papillomavirus (HPV) entry, where RAB9A associates with the L2 protein of HPV. The interaction is initially facilitated by the GTP-bound form of RAB9A, but the hydrolysis to GDP-bound RAB9A is necessary for the productive recruitment of the retromer to HPV, highlighting a noncanonical role of RAB9A in viral trafficking (Choi2023Noncanonical).

RAB9A also interacts with the cytosolic effector protein TIP47, which is crucial for the stabilization of RAB9A on endosomal membranes. TIP47 binds to RAB9A with high affinity, particularly when RAB9A is in its GTP-bound form, and this interaction is necessary for the recycling of mannose 6-phosphate receptors (Ganley2004Rab9). These interactions underscore the role of RAB9A in regulating endosomal trafficking and its involvement in both cellular and viral processes.


## References


[1. (Mackiewicz2009Phylogeny) Paweł Mackiewicz and Elżbieta Wyroba. Phylogeny and evolution of rab7 and rab9 proteins. BMC Evolutionary Biology, 9(1):101, 2009. URL: http://dx.doi.org/10.1186/1471-2148-9-101, doi:10.1186/1471-2148-9-101. This article has 26 citations.](https://doi.org/10.1186/1471-2148-9-101)

[2. (Liang2019Long) Lili Liang, Zhixin Zhang, Xiaowei Qin, Ying Gao, Peng Zhao, Jing Liu, and Weihui Zeng. Long noncoding rna zfas1 promotes tumorigenesis through regulation of mir-150-5p/rab9a in melanoma. Melanoma Research, 29(6):569–581, December 2019. URL: http://dx.doi.org/10.1097/cmr.0000000000000595, doi:10.1097/cmr.0000000000000595. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/cmr.0000000000000595)

[3. (Xu2021Circular) Yining Xu, Teng Yao, Haonan Ni, Rujie Zheng, Kangmao Huang, Yizhen Huang, Jun Gao, Di Qiao, Shuying Shen, and Jianjun Ma. Circular rna circsipa1l1 contributes to osteosarcoma progression through the mir-411-5p/rab9a signaling pathway. Frontiers in Cell and Developmental Biology, April 2021. URL: http://dx.doi.org/10.3389/fcell.2021.642605, doi:10.3389/fcell.2021.642605. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2021.642605)

[4. (Ouyang2021Loss) Xiwu Ouyang, Lei Yao, Guodong Liu, Shiqing Liu, Liansheng Gong, and Yao Xiao. Loss of androgen receptor promotes hcc invasion and metastasis via activating circ-lnpep/mir-532–3p/rab9a signal under hypoxia. Biochemical and Biophysical Research Communications, 557:26–32, June 2021. URL: http://dx.doi.org/10.1016/j.bbrc.2021.02.120, doi:10.1016/j.bbrc.2021.02.120. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2021.02.120)

[5. (Mahanty2015Rab9A) Sarmistha Mahanty, Keerthana Ravichandran, Praneeth Chitirala, Jyothi Prabha, Riddhi Atul Jani, and Subba Rao gangi Setty. Rab9a is required for delivery of cargo from recycling endosomes to melanosomes. Pigment Cell &amp; Melanoma Research, 29(1):43–59, December 2015. URL: http://dx.doi.org/10.1111/pcmr.12434, doi:10.1111/pcmr.12434. This article has 30 citations.](https://doi.org/10.1111/pcmr.12434)

[6. (Lombardi1993Rab9) D. Lombardi, T. Soldati, M.A. Riederer, Y. Goda, M. Zerial, and S.R. Pfeffer. Rab9 functions in transport between late endosomes and the trans golgi network. The EMBO Journal, 12(2):677–682, February 1993. URL: http://dx.doi.org/10.1002/j.1460-2075.1993.tb05701.x, doi:10.1002/j.1460-2075.1993.tb05701.x. This article has 423 citations.](https://doi.org/10.1002/j.1460-2075.1993.tb05701.x)

[7. (Barnekow2009Chapter) Angelika Barnekow, Anika Thyrock, and Daniel Kessler. Chapter 5 Rab Proteins and Their Interaction Partners, pages 235–274. Elsevier, 2009. URL: http://dx.doi.org/10.1016/S1937-6448(08)02005-4, doi:10.1016/s1937-6448(08)02005-4. This article has 32 citations.](https://doi.org/10.1016/S1937-6448(08)02005-4)

[8. (Choi2023Noncanonical) Jeongjoon Choi and Daniel DiMaio. Noncanonical rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry. PLOS Pathogens, 19(9):e1011648, September 2023. URL: http://dx.doi.org/10.1371/journal.ppat.1011648, doi:10.1371/journal.ppat.1011648. This article has 3 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.ppat.1011648)

[9. (Kloer2010Assembly) Daniel P. Kloer, Raul Rojas, Viorica Ivan, Kengo Moriyama, Thijs van Vlijmen, Namita Murthy, Rodolfo Ghirlando, Peter van der Sluijs, James H. Hurley, and Juan S. Bonifacino. Assembly of the biogenesis of lysosome-related organelles complex-3 (bloc-3) and its interaction with rab9. Journal of Biological Chemistry, 285(10):7794–7804, March 2010. URL: http://dx.doi.org/10.1074/jbc.m109.069088, doi:10.1074/jbc.m109.069088. This article has 87 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m109.069088)

[10. (Wu2023Isoliquiritigenin) Songjiang Wu and Jian Wang. Isoliquiritigenin regulates the circ_0002860/mir-431-5p/rab9a axis to function as a tumor inhibitor in melanoma. Journal of Venomous Animals and Toxins including Tropical Diseases, 2023. URL: http://dx.doi.org/10.1590/1678-9199-jvatitd-2022-0019, doi:10.1590/1678-9199-jvatitd-2022-0019. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1590/1678-9199-jvatitd-2022-0019)

[11. (Ganley2004Rab9) Ian G. Ganley, Kate Carroll, Lenka Bittova, and Suzanne Pfeffer. Rab9 gtpase regulates late endosome size and requires effector interaction for its stability. Molecular Biology of the Cell, 15(12):5420–5430, December 2004. URL: http://dx.doi.org/10.1091/mbc.e04-08-0747, doi:10.1091/mbc.e04-08-0747. This article has 136 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e04-08-0747)